{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:30:10Z","timestamp":1793745010331,"version":"4.6.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T00:00:00Z","timestamp":1496880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T00:00:00Z","timestamp":1496880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>GTP cyclohydrolase 1 (GCH1) and its product tetrahydrobiopterin play crucial roles in cardiovascular health and disease, yet the exact regulation and role of GCH1 in adverse cardiac remodeling after myocardial infarction are still enigmatic. Here we report that cardiac GCH1 is degraded in remodeled hearts after myocardial infarction, concomitant with increases in the thickness of interventricular septum, interstitial fibrosis, and phosphorylated p38 mitogen-activated protein kinase and decreases in left ventricular anterior wall thickness, cardiac contractility, tetrahydrobiopterin, the dimers of nitric oxide synthase, sarcoplasmic reticulum Ca<jats:sup>2+<\/jats:sup> release, and the expression of sarcoplasmic reticulum Ca<jats:sup>2+<\/jats:sup> handling proteins. Intriguingly, transgenic overexpression of GCH1 in cardiomyocytes reduces the thickness of interventricular septum and interstitial fibrosis and increases anterior wall thickness and cardiac contractility after infarction. Moreover, we show that GCH1 overexpression decreases phosphorylated p38 mitogen-activated protein kinase and elevates tetrahydrobiopterin levels, the dimerization and phosphorylation of neuronal nitric oxide synthase, sarcoplasmic reticulum Ca<jats:sup>2+<\/jats:sup> release, and sarcoplasmic reticulum Ca<jats:sup>2+<\/jats:sup> handling proteins in post-infarction remodeled hearts. Our results indicate that the pivotal role of GCH1 overexpression in post-infarction cardiac remodeling is attributable to preservation of neuronal nitric oxide synthase and sarcoplasmic reticulum Ca<jats:sup>2+<\/jats:sup> handling proteins, and identify a new therapeutic target for cardiac remodeling after infarction.<\/jats:p>","DOI":"10.1038\/s41598-017-03234-6","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T13:42:42Z","timestamp":1496410962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Transgenic overexpression of GTP cyclohydrolase 1 in cardiomyocytes ameliorates post-infarction cardiac remodeling"],"prefix":"10.1038","volume":"7","author":[{"given":"Yanan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley L.","family":"Baumgardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigang","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeljko J.","family":"Bosnjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"V\u00e1squez-Vivar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Warltier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy R.","family":"Kersten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7045-0846","authenticated-orcid":false,"given":"Zhi-Dong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,8]]},"reference":[{"key":"3234_CR1","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1161\/CIR.0000000000000350","volume":"133","author":"D Mozaffarian","year":"2016","unstructured":"Mozaffarian, D. et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation \n                           133, e38\u2013360 (2016).","journal-title":"Circulation"},{"key":"3234_CR2","first-page":"14","volume":"0","author":"N Townsend","year":"2016","unstructured":"Townsend, N. et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J \n                           0, 14 (2016).","journal-title":"Eur Heart J"},{"key":"3234_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jcmg.2010.10.008","volume":"4","author":"MA Konstam","year":"2011","unstructured":"Konstam, M. A., Kramer, D. G., Patel, A. R., Maron, M. S. & Udelson, J. E. Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC. Cardiovasc Imag \n                           4, 98\u2013108 (2011).","journal-title":"JACC. Cardiovasc Imag"},{"key":"3234_CR4","doi-asserted-by":"publisher","first-page":"2579832","DOI":"10.1155\/2016\/2579832","volume":"2016","author":"A Galli","year":"2016","unstructured":"Galli, A. & Lombardi, F. Postinfarct left ventricular remodelling: a prevailing cause of heart failure. Cardiol Res Practice \n                           2016, 2579832 (2016).","journal-title":"Cardiol Res Practice"},{"key":"3234_CR5","doi-asserted-by":"publisher","first-page":"e002416","DOI":"10.1161\/CIRCHEARTFAILURE.115.002416","volume":"9","author":"M Nayor","year":"2016","unstructured":"Nayor, M., Enserro, D. M., Vasan, R. S. & Xanthakis, V. Cardiovascular health status and incidence of heart failure in the Framingham offspring study. Circ Heart Fail \n                           9, e002416 (2016).","journal-title":"Circ Heart Fail"},{"key":"3234_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.ahj.2015.06.013","volume":"170","author":"MA Daubert","year":"2015","unstructured":"Daubert, M. A. et al. High-risk percutaneous coronary intervention is associated with reverse left ventricular remodeling and improved outcomes in patients with coronary artery disease and reduced ejection fraction. Am Heart J \n                           170, 550\u2013558 (2015).","journal-title":"Am Heart J"},{"key":"3234_CR7","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1161\/CIRCULATIONAHA.108.813493","volume":"118","author":"PS Jhund","year":"2008","unstructured":"Jhund, P. S. & McMurray, J. J. Heart failure after acute myocardial infarction: a lost battle in the war on heart failure? Circulation \n                           118, 2019\u20132021 (2008).","journal-title":"Circulation"},{"key":"3234_CR8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/clc.20922","volume":"34","author":"MF Minicucci","year":"2011","unstructured":"Minicucci, M. F., Azevedo, P. S., Polegato, B. F., Paiva, S. A. & Zornoff, L. A. Heart failure after myocardial infarction: clinical implications and treatment. Clin Cardiol \n                           34, 410\u2013414 (2011).","journal-title":"Clin Cardiol"},{"key":"3234_CR9","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/CIRCRESAHA.115.307647","volume":"118","author":"XL Tang","year":"2016","unstructured":"Tang, X. L. et al. Long-term outcome of administration of c-kitPOS cardiac progenitor cells after acute myocardial infarction: transplanted cells do not become cardiomyocytes, but structural and functional improvement and proliferation of endogenous cells persist for at least one year. Circ Res \n                           118, 1091\u20131105 (2016).","journal-title":"Circ Res"},{"key":"3234_CR10","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/CIRCRESAHA.115.307676","volume":"118","author":"PP Zwetsloot","year":"2016","unstructured":"Zwetsloot, P. P. et al. Cardiac stem cell treatment in myocardial infarction: a systematic review and meta-analysis of preclinical studies. Circ Res \n                           118, 1223\u20131232 (2016).","journal-title":"Circ Res"},{"key":"3234_CR11","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.115.307347","volume":"118","author":"M Gyongyosi","year":"2016","unstructured":"Gyongyosi, M., Wojakowski, W., Navarese, E. P. & Moye, L. A. Meta-analyses of human cell-based cardiac regeneration therapies: controversies in meta-analyses results on cardiac cell-based regenerative studies. Circ Res \n                           118, 1254\u20131263 (2016).","journal-title":"Circ Res"},{"key":"3234_CR12","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1089\/ars.2013.5566","volume":"20","author":"JK Bendall","year":"2014","unstructured":"Bendall, J. K., Douglas, G., McNeill, E., Channon, K. M. & Crabtree, M. J. Tetrahydrobiopterin in cardiovascular health and disease. Antioxid Redox Signal \n                           20, 3040\u20133077 (2014).","journal-title":"Antioxid Redox Signal"},{"key":"3234_CR13","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/HYPERTENSIONAHA.108.123422","volume":"53","author":"AF Ceylan-Isik","year":"2009","unstructured":"Ceylan-Isik, A. F. et al. Metallothionein abrogates GTP cyclohydrolase I inhibition-induced cardiac contractile and morphological defects: role of mitochondrial biogenesis. Hypertension \n                           53, 1023\u20131031 (2009).","journal-title":"Hypertension"},{"key":"3234_CR14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/cvr\/cvr079","volume":"91","author":"ZD Ge","year":"2011","unstructured":"Ge, Z. D. et al. Cardiac-specific overexpression of GTP cyclohydrolase 1 restores ischaemic preconditioning during hyperglycaemia. Cardiovasc Res \n                           91, 340\u2013349 (2011).","journal-title":"Cardiovasc Res"},{"key":"3234_CR15","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1161\/CIRCRESAHA.112.274464","volume":"111","author":"R Carnicer","year":"2012","unstructured":"Carnicer, R. et al. Cardiomyocyte GTP cyclohydrolase 1 and tetrahydrobiopterin increase NOS1 activity and accelerate myocardial relaxation. Circ Res \n                           111, 718\u2013727 (2012).","journal-title":"Circ Res"},{"key":"3234_CR16","doi-asserted-by":"publisher","first-page":"27825","DOI":"10.1038\/srep27825","volume":"6","author":"HE Wu","year":"2016","unstructured":"Wu, H. E. et al. Cardiomyocyte GTP cyclohydrolase 1 protects the heart against diabetic cardiomyopathy. Sci Rep \n                           6, 27825 (2016).","journal-title":"Sci Rep"},{"key":"3234_CR17","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/mt.2015.8","volume":"23","author":"E Cederfjall","year":"2015","unstructured":"Cederfjall, E., Broom, L. & Kirik, D. Controlled striatal DOPA production from a gene delivery system in a rodent model of Parkinson\u2019s disease. Mol Ther \n                           23, 896\u2013906 (2015).","journal-title":"Mol Ther"},{"key":"3234_CR18","doi-asserted-by":"publisher","first-page":"11998","DOI":"10.1038\/srep11998","volume":"5","author":"T Wei","year":"2015","unstructured":"Wei, T. et al. Metabonomic analysis of potential biomarkers and drug targets involved in diabetic nephropathy mice. Sci Rep \n                           5, 11998 (2015).","journal-title":"Sci Rep"},{"key":"3234_CR19","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/j.freeradbiomed.2011.09.012","volume":"51","author":"J Belik","year":"2011","unstructured":"Belik, J. et al. Pulmonary hypertension in the newborn GTP cyclohydrolase I-deficient mouse. Free Radic Biol Med \n                           51, 2227\u20132233 (2011).","journal-title":"Free Radic Biol Med"},{"key":"3234_CR20","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.2337\/db13-0751","volume":"62","author":"Y Zhao","year":"2013","unstructured":"Zhao, Y., Wu, J., Zhu, H., Song, P. & Zou, M. H. Peroxynitrite-dependent zinc release and inactivation of guanosine 5\u2019-triphosphate cyclohydrolase 1 instigate its ubiquitination in diabetes. Diabetes \n                           62, 4247\u20134256 (2013).","journal-title":"Diabetes"},{"key":"3234_CR21","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1161\/HYPERTENSIONAHA.114.03089","volume":"64","author":"S Chuaiphichai","year":"2014","unstructured":"Chuaiphichai, S. et al. Cell-autonomous role of endothelial GTP cyclohydrolase 1 and tetrahydrobiopterin in blood pressure regulation. Hypertension \n                           64, 530\u2013540 (2014).","journal-title":"Hypertension"},{"key":"3234_CR22","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1161\/CIRCULATIONAHA.116.017949","volume":"134","author":"P Li","year":"2016","unstructured":"Li, P. et al. Inhibition of aberrant microRNA-133a expression in endothelial cells by statin prevents endothelial dysfunction by targeting GTP cyclohydrolase 1 in vivo. Circulation \n                           134, 1752\u20131765 (2016).","journal-title":"Circulation"},{"key":"3234_CR23","first-page":"13728","volume":"2017","author":"S Chuaiphichai","year":"2017","unstructured":"Chuaiphichai, S. et al. A key role for tetrahydrobiopterin-dependent endothelial NOS regulation in vascular resistance arteries: studies in endothelial cell tetrahydrobiopterin-deficient Mice. Br J Pharmacol \n                           2017, 13728 (2017).","journal-title":"Br J Pharmacol"},{"key":"3234_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.braindev.2008.05.012","volume":"31","author":"T Ikeda","year":"2009","unstructured":"Ikeda, T. et al. Segawa disease with a novel heterozygous mutation in exon 5 of the GCH-1 gene (E183K). Brain Dev \n                           31, 173\u2013175 (2009).","journal-title":"Brain Dev"},{"key":"3234_CR25","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nrneurol.2015.86","volume":"11","author":"S Wijemanne","year":"2015","unstructured":"Wijemanne, S. & Jankovic, J. Dopa-responsive dystonia\u2013clinical and genetic heterogeneity. Nat Rev Neurol \n                           11, 414\u2013424 (2015).","journal-title":"Nat Rev Neurol"},{"key":"3234_CR26","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/ALN.0000000000000778","volume":"123","author":"I Baotic","year":"2015","unstructured":"Baotic, I. et al. Isoflurane favorably modulates guanosine triphosphate cyclohydrolase-1 and endothelial nitric oxide synthase during myocardial ischemia and reperfusion injury in rats. Anesthesiology \n                           123, 582\u2013589 (2015).","journal-title":"Anesthesiology"},{"key":"3234_CR27","doi-asserted-by":"publisher","first-page":"e002368","DOI":"10.1161\/CIRCHEARTFAILURE.115.002368","volume":"9","author":"Y Shimizu","year":"2016","unstructured":"Shimizu, Y. et al. Sodium sulfide attenuates ischemic-induced heart failure by enhancing proteasomal function in an Nrf2-dependent manner. Circ Heart Fail \n                           9, e002368 (2016).","journal-title":"Circ Heart Fail"},{"key":"3234_CR28","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","volume":"33","author":"U Forstermann","year":"2012","unstructured":"Forstermann, U. & Sessa, W. C. Nitric oxide synthases: regulation and function. Eur Heart J \n                           33, 829\u2013837 (2012). 837a\u2013837d.","journal-title":"Eur Heart J"},{"key":"3234_CR29","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/cvr\/cvv219","volume":"108","author":"A Lucas","year":"2015","unstructured":"Lucas, A. et al. Gadd45\u03b3 regulates cardiomyocyte death and post-myocardial infarction left ventricular remodelling. Cardiovasc Res \n                           108, 254\u2013267 (2015).","journal-title":"Cardiovasc Res"},{"key":"3234_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2174\/157340641202160209094548","volume":"12","author":"PA Davlouros","year":"2016","unstructured":"Davlouros, P. A. et al. Calcium homeostasis and kinetics in heart failure. Med Chem \n                           12, 151\u2013161 (2016).","journal-title":"Med Chem"},{"key":"3234_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jnutbio.2015.09.025","volume":"28","author":"P Raj","year":"2016","unstructured":"Raj, P. et al. Resveratrol is equipotent to perindopril in attenuating post-infarct cardiac remodeling and contractile dysfunction in rats. J Nutr Biochem \n                           28, 155\u2013163 (2016).","journal-title":"J Nutr Biochem"},{"key":"3234_CR32","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1124\/jpet.106.111351","volume":"319","author":"ZD Ge","year":"2006","unstructured":"Ge, Z. D. et al. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5\u2019-N-methylcarboxamide] reduces ischemia\/reperfusion injury in mice by activating the A3 adenosine receptor. J Pharmacol Exp Ther \n                           319, 1200\u20131210 (2006).","journal-title":"J Pharmacol Exp Ther"},{"key":"3234_CR33","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.yjmcc.2010.01.018","volume":"49","author":"ZD Ge","year":"2010","unstructured":"Ge, Z. D., van der Hoeven, D., Maas, J. E., Wan, T. C. & Auchampach, J. A. A3 adenosine receptor activation during reperfusion reduces infarct size through actions on bone marrow-derived cells. J Mol Cell Cardiol \n                           49, 280\u2013286 (2010).","journal-title":"J Mol Cell Cardiol"},{"key":"3234_CR34","doi-asserted-by":"publisher","first-page":"20711","DOI":"10.1038\/srep20711","volume":"6","author":"LY Lin","year":"2016","unstructured":"Lin, L. Y. et al. Myocardial regional interstitial fibrosis is associated with left intra-ventricular dyssynchrony in patients with heart failure: a cardiovascular magnetic resonance study. Sci Rep \n                           6, 20711 (2016).","journal-title":"Sci Rep"},{"key":"3234_CR35","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nature07511","volume":"456","author":"T Thum","year":"2008","unstructured":"Thum, T. et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature \n                           456, 980\u2013984 (2008).","journal-title":"Nature"},{"key":"3234_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fphar.2015.00102","volume":"6","author":"P Arabacilar","year":"2015","unstructured":"Arabacilar, P. & Marber, M. The case for inhibiting p38 mitogen-activated protein kinase in heart failure. Front Pharmacol \n                           6, 102 (2015).","journal-title":"Front Pharmacol"},{"key":"3234_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/ALN.0b013e3181c4a607","volume":"112","author":"ZD Ge","year":"2010","unstructured":"Ge, Z. D. et al. Isoflurane postconditioning protects against reperfusion injury by preventing mitochondrial permeability transition by an endothelial nitric oxide synthase-dependent mechanism. Anesthesiology \n                           112, 73\u201385 (2010).","journal-title":"Anesthesiology"},{"key":"3234_CR38","doi-asserted-by":"publisher","first-page":"e002424","DOI":"10.1161\/CIRCHEARTFAILURE.115.002424","volume":"9","author":"SL Baumgardt","year":"2016","unstructured":"Baumgardt, S. L. et al. Chronic co-administration of sepiapterin and L-citrulline ameliorates diabetic cardiomyopathy and myocardial ischemia\/reperfusion injury in obese type 2 diabetic mice. Circ Heart Fail \n                           9, e002424 (2016).","journal-title":"Circ Heart Fail"},{"key":"3234_CR39","doi-asserted-by":"publisher","first-page":"a004242","DOI":"10.1101\/cshperspect.a004242","volume":"3","author":"CJ Fearnley","year":"2011","unstructured":"Fearnley, C. J., Roderick, H. L. & Bootman, M. D. Calcium signaling in cardiac myocytes. Cold Spring Harb Perspect Biol \n                           3, a004242 (2011).","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3234_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cmet.2015.01.005","volume":"21","author":"PA Gorski","year":"2015","unstructured":"Gorski, P. A., Ceholski, D. K. & Hajjar, R. J. Altered myocardial calcium cycling and energetics in heart failure\u2013a rational approach for disease treatment. Cell Metab \n                           21, 183\u2013194 (2015).","journal-title":"Cell Metab"},{"key":"3234_CR41","doi-asserted-by":"publisher","first-page":"e0153887","DOI":"10.1371\/journal.pone.0153887","volume":"11","author":"M Sadredini","year":"2016","unstructured":"Sadredini, M. et al. \u03b2-Adrenoceptor stimulation reveals Ca2+ waves and sarcoplasmic reticulum Ca2+ depletion in left ventricular cardiomyocytes from post-infarction rats with and without heart failure. PloS ONE \n                           11, e0153887 (2016).","journal-title":"PloS ONE"},{"key":"3234_CR42","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S0735-1097(01)01433-4","volume":"38","author":"A Rapacciuolo","year":"2001","unstructured":"Rapacciuolo, A. et al. Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy. J Am Coll Cardiol \n                           38, 876\u2013882 (2001).","journal-title":"J Am Coll Cardiol"},{"key":"3234_CR43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.yjmcc.2014.12.004","volume":"83","author":"HA Feridooni","year":"2015","unstructured":"Feridooni, H. A., Dibb, K. M. & Howlett, S. E. How cardiomyocyte excitation, calcium release and contraction become altered with age. J Mol Cell Cardiol \n                           83, 62\u201372 (2015).","journal-title":"J Mol Cell Cardiol"},{"key":"3234_CR44","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/hum.2015.018","volume":"26","author":"C Hayward","year":"2015","unstructured":"Hayward, C., Banner, N. R., Morley-Smith, A., Lyon, A. R. & Harding, S. E. The current and future landscape of SERCA gene therapy for heart failure: a clinical perspective. Human Gene Ther \n                           26, 293\u2013304 (2015).","journal-title":"Human Gene Ther"},{"key":"3234_CR45","doi-asserted-by":"publisher","first-page":"21510","DOI":"10.1074\/jbc.M116.738807","volume":"291","author":"KJ Soller","year":"2016","unstructured":"Soller, K. J., Yang, J., Veglia, G. & Bowser, M. T. Reversal of phospholamban inhibition of the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) using short protein interacting RNAs and oligonucleotide analogs. J Biol Chem \n                           291, 21510\u201321518 (2016).","journal-title":"J Biol Chem"},{"key":"3234_CR46","doi-asserted-by":"publisher","first-page":"e003208","DOI":"10.1161\/JAHA.116.003208","volume":"5","author":"T Hashimoto","year":"2016","unstructured":"Hashimoto, T. et al. Tetrahydrobiopterin protects against hypertrophic heart disease independent of myocardial nitric oxide synthase coupling. J Am Heart Ass \n                           5, e003208 (2016).","journal-title":"J Am Heart Ass"},{"key":"3234_CR47","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1161\/CIRCULATIONAHA.105.539437","volume":"112","author":"D Dawson","year":"2005","unstructured":"Dawson, D. et al. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation \n                           112, 3729\u20133737 (2005).","journal-title":"Circulation"},{"key":"3234_CR48","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1161\/CIRCULATIONAHA.109.883777","volume":"121","author":"GA Silberman","year":"2010","unstructured":"Silberman, G. A. et al. Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction. Circulation \n                           121, 519\u2013528 (2010).","journal-title":"Circulation"},{"key":"3234_CR49","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.vph.2012.02.004","volume":"57","author":"ND Roe","year":"2012","unstructured":"Roe, N. D. & Ren, J. Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases. Vasc Pharmacol \n                           57, 168\u2013172 (2012).","journal-title":"Vasc Pharmacol"},{"key":"3234_CR50","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/21224","volume":"399","author":"S Dimmeler","year":"1999","unstructured":"Dimmeler, S. et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature \n                           399, 601\u2013605 (1999).","journal-title":"Nature"},{"key":"3234_CR51","doi-asserted-by":"publisher","first-page":"27038","DOI":"10.1074\/jbc.M802269200","volume":"283","author":"CA Chen","year":"2008","unstructured":"Chen, C. A., Druhan, L. J., Varadharaj, S., Chen, Y. R. & Zweier, J. L. Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme. J Biol Chem \n                           283, 27038\u201327047 (2008).","journal-title":"J Biol Chem"},{"key":"3234_CR52","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1172\/JCI17786","volume":"112","author":"NJ Alp","year":"2003","unstructured":"Alp, N. J. et al. Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. J Clin Invest \n                           112, 725\u2013735 (2003).","journal-title":"J Clin Invest"},{"key":"3234_CR53","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1074\/jbc.M805403200","volume":"284","author":"MJ Crabtree","year":"2009","unstructured":"Crabtree, M. J. et al. Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression. J Biol Chem \n                           284, 1136\u20131144 (2009).","journal-title":"J Biol Chem"},{"key":"3234_CR54","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/01.RES.0000187447.03525.72","volume":"97","author":"JK Bendall","year":"2005","unstructured":"Bendall, J. K. et al. Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression. Circ Res \n                           97, 864\u2013871 (2005).","journal-title":"Circ Res"},{"key":"3234_CR55","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/cvr\/cvp309","volume":"85","author":"X Yu","year":"2010","unstructured":"Yu, X. & Kem, D. C. Proteasome inhibition during myocardial infarction. Cardiovasc Res \n                           85, 312\u2013320 (2010).","journal-title":"Cardiovasc Res"},{"key":"3234_CR56","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.106.684795","volume":"116","author":"J Xu","year":"2007","unstructured":"Xu, J. et al. Proteasome-dependent degradation of guanosine 5\u2019-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation \n                           116, 944\u2013953 (2007).","journal-title":"Circulation"},{"key":"3234_CR57","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1161\/ATVBAHA.107.153742","volume":"27","author":"J Whitsett","year":"2007","unstructured":"Whitsett, J., Picklo, M. J. Sr. & Vasquez-Vivar, J. 4-Hydroxy-2-nonenal increases superoxide anion radical in endothelial cells via stimulated GTP cyclohydrolase proteasomal degradation. Arterioscler Thromb Vasc Biol \n                           27, 2340\u20132347 (2007).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3234_CR58","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0008-6363(99)00274-6","volume":"45","author":"XM Gao","year":"2000","unstructured":"Gao, X. M., Dart, A. M., Dewar, E., Jennings, G. & Du, X. J. Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice. Cardiovasc Res \n                           45, 330\u2013338 (2000).","journal-title":"Cardiovasc Res"},{"key":"3234_CR59","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.yjmcc.2016.01.001","volume":"91","author":"EP Daskalopoulos","year":"2016","unstructured":"Daskalopoulos, E. P., Dufeys, C., Bertrand, L., Beauloye, C. & Horman, S. AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation. J Mol Cell Cardiol \n                           91, 188\u2013200 (2016).","journal-title":"J Mol Cell Cardiol"},{"key":"3234_CR60","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.cjca.2014.07.747","volume":"30","author":"S Liu","year":"2014","unstructured":"Liu, S. et al. Micro-RNA 21 targets dual specific phosphatase 8 to promote collagen synthesis in high glucose-treated primary cardiac fibroblasts. Can J Cardiol \n                           30, 1689\u20131699 (2014).","journal-title":"Can J Cardiol"},{"key":"3234_CR61","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1161\/01.CIR.102.15.1840","volume":"102","author":"AJ Prahash","year":"2000","unstructured":"Prahash, A. J., Gupta, S. & Anand, I. S. Myocyte response to \u03b2-adrenergic stimulation is preserved in the noninfarcted myocardium of globally dysfunctional rat hearts after myocardial infarction. Circulation \n                           102, 1840\u20131846 (2000).","journal-title":"Circulation"},{"key":"3234_CR62","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1161\/CIRCULATIONAHA.111.044255","volume":"125","author":"PW Raake","year":"2012","unstructured":"Raake, P. W. et al. Cardiac G-protein-coupled receptor kinase 2 ablation induces a novel Ca2+ handling phenotype resistant to adverse alterations and remodeling after myocardial infarction. Circulation \n                           125, 2108\u20132118 (2012).","journal-title":"Circulation"},{"key":"3234_CR63","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1042\/CS20150609","volume":"130","author":"I Schuster","year":"2016","unstructured":"Schuster, I. et al. Cardiomyocyte-specific overexpression of oestrogen receptor beta improves survival and cardiac function after myocardial infarction in female and male mice. Clinl Sci \n                           130, 365\u2013376 (2016).","journal-title":"Clinl Sci"},{"key":"3234_CR64","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/01.fjc.0000201360.71813.8a","volume":"47","author":"T Wajima","year":"2006","unstructured":"Wajima, T., Shimizu, S., Hiroi, T., Ishii, M. & Kiuchi, Y. Reduction of myocardial infarct size by tetrahydrobiopterin: possible involvement of mitochondrial KATP channels activation through nitric oxide production. J Cardiovasc Pharmacol \n                           47, 243\u2013249 (2006).","journal-title":"J Cardiovasc Pharmacol"},{"key":"3234_CR65","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ijcard.2013.08.075","volume":"169","author":"Y Tratsiakovich","year":"2013","unstructured":"Tratsiakovich, Y. et al. Myocardial protection by co-administration of L-arginine and tetrahydrobiopterin during ischemia and reperfusion. Int J Cardiol \n                           169, 83\u201388 (2013).","journal-title":"Int J Cardiol"},{"key":"3234_CR66","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.transproceed.2004.12.051","volume":"37","author":"Y Hara","year":"2005","unstructured":"Hara, Y. et al. Beneficial effect of tetrahydrobiopterin on the survival of rats exposed to hepatic ischemia-reperfusion injury. Transplant Proc \n                           37, 442\u2013444 (2005).","journal-title":"Transplant Proc"},{"key":"3234_CR67","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.surg.2005.08.019","volume":"139","author":"Y Hara","year":"2006","unstructured":"Hara, Y., Teramoto, K., Ishidate, K. & Arii, S. Cytoprotective function of tetrahydrobiopterin in rat liver ischemia\/reperfusion injury. Surgery \n                           139, 377\u2013384 (2006).","journal-title":"Surgery"},{"key":"3234_CR68","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.jss.2011.12.034","volume":"176","author":"Y Dai","year":"2012","unstructured":"Dai, Y., Cui, J., Cun, Y. & Shi, A. Tetrahydrobiopterin ameliorates hepatic ischemia-reperfusion Injury by coupling with eNOS in mice. J Surg Res \n                           176, e65\u201371 (2012).","journal-title":"J Surg Res"},{"key":"3234_CR69","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/FJC.0b013e31821f8ec3","volume":"58","author":"M Legrand","year":"2011","unstructured":"Legrand, M., Kandil, A., Payen, D. & Ince, C. Effects of sepiapterin infusion on renal oxygenation and early acute renal injury after suprarenal aortic clamping in rats. J Cardiovasc Pharmacol \n                           58, 192\u2013198 (2011).","journal-title":"J Cardiovasc Pharmacol"},{"key":"3234_CR70","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/micr.20331","volume":"27","author":"WZ Wang","year":"2007","unstructured":"Wang, W. Z., Fang, X. H., Stephenson, L. L., Khiabani, K. T. & Zamboni, W. A. Effects of supplementation of BH4 after prolonged ischemia in skeletal muscle. Microsurgery \n                           27, 200\u2013205 (2007).","journal-title":"Microsurgery"},{"key":"3234_CR71","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.atherosclerosis.2008.08.034","volume":"204","author":"M Settergren","year":"2009","unstructured":"Settergren, M., Bohm, F., Malmstrom, R. E., Channon, K. M. & Pernow, J. L-arginine and tetrahydrobiopterin protects against ischemia\/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease. Atherosclerosis \n                           204, 73\u201378 (2009).","journal-title":"Atherosclerosis"},{"key":"3234_CR72","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.yjmcc.2015.06.015","volume":"86","author":"L Xie","year":"2015","unstructured":"Xie, L., Talukder, M. A., Sun, J., Varadharaj, S. & Zweier, J. L. Liposomal tetrahydrobiopterin preserves eNOS coupling in the post-ischemic heart conferring in vivo cardioprotection. J Mol Cell Cardiol \n                           86, 14\u201322 (2015).","journal-title":"J Mol Cell Cardiol"},{"key":"3234_CR73","doi-asserted-by":"crossref","first-page":"H1782","DOI":"10.1152\/ajpheart.00417.2015","volume":"309","author":"K Yoshioka","year":"2015","unstructured":"Yoshioka, K. et al. Sepiapterin prevents left ventricular hypertrophy and dilatory remodeling induced by pressure overload in rats. Am J Physiol Heart Circ Physiol \n                           309, H1782\u20131791 (2015).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3234_CR74","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1089\/ars.2009.2453","volume":"11","author":"H Otani","year":"2009","unstructured":"Otani, H. The role of nitric oxide in myocardial repair and remodeling. Antioxid Redox Signal \n                           11, 1913\u20131928 (2009).","journal-title":"Antioxid Redox Signal"},{"key":"3234_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2016.01.019","volume":"93","author":"S Sethumadhavan","year":"2016","unstructured":"Sethumadhavan, S. et al. Increasing tetrahydrobiopterin in cardiomyocytes adversely affects cardiac redox state and mitochondrial function independently of changes in NO production. Free Radic Biol Med \n                           93, 1\u201311 (2016).","journal-title":"Free Radic Biol Med"},{"key":"3234_CR76","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.yjmcc.2011.09.006","volume":"52","author":"YH Zhang","year":"2012","unstructured":"Zhang, Y. H. & Casadei, B. Sub-cellular targeting of constitutive NOS in health and disease. J Mol Cell Cardiol \n                           52, 341\u2013350 (2012).","journal-title":"J Mol Cell Cardiol"},{"key":"3234_CR77","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1113\/jphysiol.2013.270306","volume":"592","author":"YH Zhang","year":"2014","unstructured":"Zhang, Y. H., Jin, C. Z., Jang, J. H. & Wang, Y. Molecular mechanisms of neuronal nitric oxide synthase in cardiac function and pathophysiology. J Physiol \n                           592, 3189\u20133200 (2014).","journal-title":"J Physiol"},{"key":"3234_CR78","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jphs.2014.10.002","volume":"127","author":"M Tsutsui","year":"2015","unstructured":"Tsutsui, M. et al. Significance of nitric oxide synthases: Lessons from triple nitric oxide synthases null mice. J Pharmacol Sci \n                           127, 42\u201352 (2015).","journal-title":"J Pharmacol Sci"},{"key":"3234_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.niox.2010.03.001","volume":"23","author":"S Daff","year":"2010","unstructured":"Daff, S. NO synthase: structures and mechanisms. Nitric oxide \n                           23, 1\u201311 (2010).","journal-title":"Nitric oxide"},{"key":"3234_CR80","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1681\/ASN.2006010083","volume":"17","author":"SH Lecker","year":"2006","unstructured":"Lecker, S. H., Goldberg, A. L. & Mitch, W. E. Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol \n                           17, 1807\u20131819 (2006).","journal-title":"J Am Soc Nephrol"},{"key":"3234_CR81","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bbrc.2015.10.144","volume":"468","author":"T Inobe","year":"2015","unstructured":"Inobe, T. & Genmei, R. Inhibition of the 26S proteasome by peptide mimics of the coiled-coil region of its ATPase subunits. Biochem Biophys Res Commun \n                           468, 143\u2013150 (2015).","journal-title":"Biochem Biophys Res Commun"},{"key":"3234_CR82","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1097\/ALN.0000000000000807","volume":"123","author":"S Qiao","year":"2015","unstructured":"Qiao, S. et al. MicroRNA-21 mediates isoflurane-induced cardioprotection against ischemia-reperfusion injury via Akt\/nitric oxide synthase\/mitochondrial permeability transition pore pathway. Anesthesiology \n                           123, 786\u2013798 (2015).","journal-title":"Anesthesiology"},{"key":"3234_CR83","doi-asserted-by":"publisher","first-page":"e70088","DOI":"10.1371\/journal.pone.0070088","volume":"8","author":"TM Leucker","year":"2013","unstructured":"Leucker, T. M. et al. Impairment of endothelial-myocardial interaction increases the susceptibility of cardiomyocytes to ischemia\/reperfusion injury. PloS ONE \n                           8, e70088 (2013).","journal-title":"PloS ONE"},{"key":"3234_CR84","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/cvr\/cvn057","volume":"79","author":"M Maczewski","year":"2008","unstructured":"Maczewski, M. & Mackiewicz, U. Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart. Cardiovasc Res \n                           79, 42\u201351 (2008).","journal-title":"Cardiovasc Res"},{"key":"3234_CR85","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1161\/CIRCRESAHA.115.303831","volume":"115","author":"CA Makarewich","year":"2014","unstructured":"Makarewich, C. A. et al. Transient receptor potential channels contribute to pathological structural and functional remodeling after myocardial infarction. Circ Res \n                           115, 567\u2013580 (2014).","journal-title":"Circ Res"},{"key":"3234_CR86","doi-asserted-by":"publisher","first-page":"H2130","DOI":"10.1152\/ajpheart.01078.2010","volume":"301","author":"N Vladic","year":"2011","unstructured":"Vladic, N. et al. Decreased tetrahydrobiopterin and disrupted association of Hsp90 with eNOS by hyperglycemia impair myocardial ischemic preconditioning. Am J Physiol Heart Circ Physiol \n                           301, H2130\u20132139 (2011).","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03234-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03234-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03234-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T05:07:50Z","timestamp":1671772070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03234-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,8]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["3234"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-03234-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,8]]},"assertion":[{"value":"8 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3093"}}